InVivo Therapeutics – About the Company

InVivo Therapeutics (Other OTC: NVIV) is an early-stage biotechnology company developing innovative treatments for patients with severe spinal cord injuries (SCI). The Company initiated a pilot study with a Neuro-Spinal Scaffold device for acute SCI patients and has treated the first of five patients. InVivo has strong preclinical data using the device alone or in conjunction with seeded neural stem cells in mice, pigs, and monkeys. There are no effective treatments currently available for SCI and there is a lack of therapeutic candidates reaching late-stage clinical development, reflecting the unmet medical need and market opportunity for an effective treatment.